A supported metal catalyst was designed, characterized, and tested for aqueous phase heterogeneous hydrogenation of vinyl acetate with parahydrogen to produce 13 C‐hyperpolarized ethyl acetate for potential biomedical applications. The Rh/TiO 2 catalyst with a metal loading of 23.2 wt % produced strongly hyperpolarized 13 C‐enriched ethyl acetate‐1‐ 13 C detected at 9.4 T. An approximately 14‐fold 13 C signal enhancement was detected using circa 50 % parahydrogen gas without taking into account relaxation losses before and after polarization transfer by magnetic field cycling from nascent parahydrogen‐derived protons to 13 C nuclei. This first observation of 13 C PHIP‐hyperpolarized products over a supported metal catalyst in an aqueous medium opens up new possibilities for production of catalyst‐free aqueous solutions of nontoxic hyperpolarized contrast agents for a wide range of biomolecules amenable to the parahydrogen induced polarization by side arm hydrogenation (PHIP‐SAH) approach.
No takes yet. Share an insight, caveat, or question.
Kovtunov et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: